SEC Form 4 · accession 0001127602-18-000541
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Ross Smith
Officer — Corporate Executive VP & CFO
Period of report
Jan 2, 2018
Accepted (ET)
Jan 3, 2018 · 3:56 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 2, 2018 | S | 600 | $110.30 | D | 14,171 | D | |
| Common Stock | Jan 2, 2018 | S | 200 | $110.31 | D | 13,971 | D | |
| Common Stock | Jan 2, 2018 | S | 300 | $110.35 | D | 13,671 | D | |
| Common Stock | Jan 2, 2018 | S | 300 | $110.36 | D | 13,371 | D | |
| Common Stock | Jan 2, 2018 | S | 100 | $110.37 | D | 13,271 | D | |
| Common Stock | Jan 2, 2018 | S | 300 | $110.38 | D | 12,971 | D | |
| Common Stock | Jan 2, 2018 | S | 100 | $110.385 | D | 12,871 | D | |
| Common Stock | Jan 2, 2018 | S | 100 | $110.39 | D | 12,771 | D | |
| Common Stock | Jan 2, 2018 | S | 100 | $110.40 | D | 12,671 | D | |
| Common Stock | Jan 2, 2018 | S | 300 | $110.42 | D | 12,371 | D | |
| Common Stock | Jan 2, 2018 | S | 100 | $110.43 | D | 12,271 | D | |
| Common Stock | Jan 2, 2018 | S | 100 | $110.45 | D | 12,171 | D | |
| Common Stock | Jan 2, 2018 | S | 100 | $110.475 | D | 12,071 | D | |
| Common Stock | Jan 2, 2018 | S | 200 | $110.50 | D | 11,871 | D | |
| Common Stock | Jan 2, 2018 | S | 200 | $110.53 | D | 11,671 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.